Prime Medicine, Inc.

General ticker "PRME" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $500.6M (TTM average)

Prime Medicine, Inc. follows the US Stock Market performance with the rate: 45.7%.

Estimated limits based on current volatility of 2.9%: low 3.42$, high 3.62$

Factors to consider:

  • Earnings expected soon, date: 2026-05-07 bmo
  • Total employees count: 175 as of 2022
  • Price in estimated range

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [2.53$, 7.42$]
  • 2026-12-31 to 2027-12-31 estimated range: [2.10$, 6.29$]

Financial Metrics affecting the PRME estimates:

  • Positive: with PPE of -2.6 at the end of fiscal year the price was neutral
  • Negative: negative Operating income
  • Negative: Operating cash flow per share per price, % of -30.59 <= 0.07
  • Positive: 19.49 < Shareholder equity ratio, % of 35.27 <= 42.60
  • Negative: negative Net income
  • Positive: Interest expense per share per price, % of 0 <= 0.01
  • Positive: Industry inventory ratio change (median), % of 0 <= 0

Similar symbols

Short-term PRME quotes

Long-term PRME plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $0.00MM $2.98MM $4.63MM
Operating Expenses $204.79MM $205.45MM $212.98MM
Operating Income $-204.79MM $-202.47MM $-208.35MM
Non-Operating Income $6.38MM $6.58MM $7.21MM
R&D Expense $147.91MM $155.29MM $160.64MM
Income(Loss) $-198.41MM $-195.88MM $-201.14MM
Taxes $-0.28MM $0.00MM $0.00MM
Profit(Loss)* $-198.13MM $-195.88MM $-201.14MM
Stockholders Equity $133.07MM $153.15MM $120.87MM
Assets $193.85MM $297.51MM $342.73MM
Operating Cash Flow $-165.41MM $-122.86MM $-162.56MM
Capital expenditure $8.72MM $7.29MM $4.53MM
Investing Cash Flow $18.71MM $68.46MM $-108.76MM
Financing Cash Flow $0.66MM $195.88MM $151.51MM
Earnings Per Share** $-2.18 $-1.65 $-1.35

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.